Actively Recruiting

Phase 2
Age: 18Years +
All Genders
Healthy Volunteers
NCT01280994

Hyperpolarized 129Xe MRI for Imaging Pulmonary Function

Led by Bastiaan Driehuys · Updated on 2026-01-16

445

Participants Needed

1

Research Sites

1039 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study is to develop and evaluate the usefulness of MRI using 129Xe gas for regional assessment of pulmonary function. Specifically, three forms of 129Xe MRI contrast will be the investigators focus - 1) imaging of the 129Xe ventilation distribution, 2) imaging the alveolar microstructure via the 129Xe apparent diffusion coefficient (ADC), and 3) imaging 129Xe that dissolves in the pulmonary blood and tissues upon inhalation. Such imaging of 129Xe gas transfer is expected to be uniquely sensitive to pathologies affecting gas exchange (fibrosis, emphysema, pulmonary hypertension) and provide new insights regarding the normal resting heterogeneity of pulmonary gas exchange.

CONDITIONS

Official Title

Hyperpolarized 129Xe MRI for Imaging Pulmonary Function

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • For healthy controls: no diagnosed lung conditions
  • For healthy controls: no smoking within the past 5 years
  • For healthy controls: smoking history of 5 pack-years or less
  • For lung disease subjects: diagnosed pulmonary dysfunction by a doctor
  • For lung disease subjects: no recent worsening of lung function within 30 days
Not Eligible

You will not qualify if you...

  • Under 18 years old
  • MRI contraindicated based on screening questionnaire
  • Pregnant or breastfeeding
  • Respiratory infection within 30 days before MRI
  • Received investigational drugs (except 129Xe) within 30 days
  • Any known heart rhythm problems
  • Does not fit into the 129Xe MRI vest coil
  • Unable to hold breath for 15 seconds
  • Unlikely to follow instructions during imaging

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Duke University Medical Center

Durham, North Carolina, United States, 27710

Actively Recruiting

Loading map...

Research Team

J

Jennifer Korzekwinski

CONTACT

C

Cody Blanton

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here